{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:00:58Z","timestamp":1791489658568,"version":"4.3.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":224,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101380","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:44:06Z","timestamp":1787705046000},"page":"101380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Temporal changes in Denosumab use among patients with giant cell tumour of bone at a specialist oncology centre: a retrospective cohort study"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9344-1447","authenticated-orcid":false,"given":"Mylene J.C.","family":"Duivenvoorden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6923-8947","authenticated-orcid":false,"given":"Vineet","family":"Kurisunkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9526-3775","authenticated-orcid":false,"given":"Gerjon","family":"Hannink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0845-9257","authenticated-orcid":false,"given":"Michael","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9005-279X","authenticated-orcid":false,"given":"Lee","family":"Jeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8027-5888","authenticated-orcid":false,"given":"Floortje G.M.","family":"Verspoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctarc.2026.101380_bib0001","doi-asserted-by":"crossref","DOI":"10.1177\/2309499020979750","article-title":"The current standing on the use of denosumab in giant cell tumour of the bone","volume":"28","author":"Singh","year":"2020","journal-title":"J. Orthop. Surg."},{"key":"10.1016\/j.ctarc.2026.101380_bib0002","article-title":"Denosumab in giant cell tumor of bone: current status and pitfalls","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101380_bib0003","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/cancers14092290","article-title":"Denosumab in giant cell tumor of bone: multidisciplinary medical management based on pathophysiological mechanisms and real-world evidence","volume":"14","author":"Borkowska","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101380_bib0004","first-page":"260","article-title":"Denosumab in patients with giant cell tumor and its recurrence: a systematic review","volume":"6","author":"Jamshidi","year":"2018","journal-title":"Arch. Bone Jt. Surg."},{"key":"10.1016\/j.ctarc.2026.101380_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151479","article-title":"Spectrum of histological features of Denosumab treated Giant cell tumor of Bone; potential pitfalls and diagnostic challenges for pathologists","volume":"45","author":"Tariq","year":"2020","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.ctarc.2026.101380_bib0006","doi-asserted-by":"crossref","DOI":"10.5312\/wjo.v16.i3.102520","article-title":"Denosumab regimens in the treatment of giant cell tumor of bone: a systematic review with meta-analysis","author":"Barreto","year":"2025","journal-title":"World J. Orthop."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101380_bib0007","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/CCO.0000000000000529","article-title":"Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone","volume":"31","author":"Lipplaa","year":"2019","journal-title":"Curr. Opin. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101380_bib0009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/BRS.0000000000003728","article-title":"Denosumab treatment for giant cell tumor of the spine including the sacrum","volume":"46","author":"Bukata","year":"2021","journal-title":"Spine"},{"issue":"Supplement 5","key":"10.1016\/j.ctarc.2026.101380_bib0010","article-title":"Long-term efficacy of denosumab in giant cell tumor of bone: results of an open-label phase 2 study","volume":"28","author":"Palmerini","year":"2017","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101380_bib0011","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12957-018-1478-3","article-title":"Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone","volume":"16","author":"Engellau","year":"2018","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2026.101380_bib0012","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11657-022-01129-2","article-title":"Safety of denosumab versus zoledronic acid in the older adults with osteoporosis: a meta-analysis of cohort studies","author":"Weiwei Li","year":"2022","journal-title":"Arch. Osteoporos."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101380_bib0013","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2106\/JBJS.17.00057","article-title":"Denosumab may increase the risk of local recurrence in patients with giant-cell tumor of bone treated with curettage","volume":"100","author":"Errani","year":"2018","journal-title":"J. Bone Jt. Surg. Am."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101380_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2026.111979","article-title":"Indication-specific use of Denosumab in giant cell tumour of bone: a retrospective cohort study","volume":"52","author":"Duivenvoorden","year":"2026","journal-title":"Eur. J. Surg. Oncol."},{"issue":"15","key":"10.1016\/j.ctarc.2026.101380_bib0015","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.3390\/cancers13153647","article-title":"Current concepts in the treatment of giant cell tumors of bone","volume":"13","author":"Tsukamoto","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101380_bib0016","article-title":"A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM)","author":"Jeys","year":"2026","journal-title":"Bone Jt. J."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:41:08Z","timestamp":1791488468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":15,"alternative-id":["S2468294226002911"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101380","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal changes in Denosumab use among patients with giant cell tumour of bone at a specialist oncology centre: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101380"}}